Biomea Fusion to Participate in Jefferies London Healthcare Conference Nov. 17-18.

Biomea Fusion, a clinical-stage biopharmaceutical company, is scheduled to participate in a fireside chat at the Jefferies London Healthcare Conference on November 17, 2025. The company will also hold one-on-one meetings on November 17-18, 2025. The presentation will be available on Biomea's website and a replay will be available after the event. Biomea is developing oral small molecule therapies for diabetes and obesity, including icovamenib and BMF-650.